H. Flanner

Dissolution Fit Factors as Response Variables in Statistically Designed Experiments

Henry H. Flanner, Charles F. Vesey, Joseph R. Loehe, 2001 .

First in Human Phase 1 Single Dose Escalation Studies of the E-Selectin Antagonist GMI-1271 Show a Favorable Safety, Pharmacokinetic, and Biomarker Profile

T. Wakefield, J. Froehlich, J. Magnani, 2015 .

Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia

M. Telen, L. Decastro, T. Wun, 2014, PloS one.

Mathematical comparison of dissolution profiles

J. W. Moore, H. H. Flanner, H. Flanner, 1996 .

Pharmacodynamic Analysis and Clinical Trial of Amoxicillin Sprinkle Administered Once Daily for 7 Days Compared to Penicillin V Potassium Administered Four Times Daily for 10 Days in the Treatment of Tonsillopharyngitis Due to Streptococcus pyogenes in Children

M. Pichichero, S. Block, J. Casey, 2008, Antimicrobial Agents and Chemotherapy.

Pan-Selectin Antagonist Rivipansel (GMI-1070) Reduces Soluble E-Selectin Levels While Improving Clinical Outcomes in SCD Vaso-Occlusive Crisis

M. Telen, L. Krishnamurti, L. Decastro, 2014 .